ENCOURAGING SELF-ADMINISTRATION OF ERYTHROPOIETIN BY CREATING INFORMATION BROCHURE FOR PREDIALYSIS CKD PATIENTS
Date Issued
2024-04-04
Author(s)
Karanfilovikj, A
Trajcheska, L
Sulejman, S
Milenkova Bogojevska, M
Spasovska Vasilova, A
Usprcov, J
Stojanoska Severova, A
Memeti, A
Filipovski, S
Bedzet, B
Abstract
ENCOURAGING SELF-ADMINISTRATION OF
ERYTHROPOIETIN BY CREATING INFORMATION
BROCHURE FOR PREDIALYSIS CKD PATIENTS
A. Karanfilovikj, L. Trajcheska, S. Sulejman, A. Canevska
Taneska, M. Milenkova Bogojevska, A. Spasovska Vasilova,
Z. Shterjova Markovska, J. Usprcov, V. Karanfilovski,
A. Stojanoska Severova, Z. Janevski, A. Memeti, S.
Filipovski, B. Bedzeti, I. Rambabova Bushljetikj
University Department for Nephrology, Faculty of
Medicine, University Ss Cyril and Methodius, Skopje,
N. Macedonia
PP
Introduction. Patients with chronic kidney disease
have a relatively deficient erythropoietin production,
and this is one of the most significant causes of anemia in this group. The disorder starts to develop when
the glomerular filtration rate drops below 60 mg/ml.
In it’s severe form, anemia decreases quality of life
and increases the risk of cardiovascular diseases and
mortality in this patients, so the implementation of
prevention and control measures is recommended.
Methods. In our institution, 54 predialysis CKD patients, with average age 69,44±15, have been regularly
followed and treated for anemia with subcutaneous
administration of ESA, mostly on weekly basis. Considering the numerous comorbidities of this group of
patients, in order to reduce frequent outpatient visits
and improving the quality of life, 30 (60%) patients
accepted to be educated on self-administration of EPO.
Results. We created an information brochure for patients, as an educational training material, with basic
information about the medication, how to administer,
side effects, contraindications and information about
safe storage and disposal.
Conclusion. The benefits of education through the
information brochure for self-application of EPO among
the group of predialysis CKD patients are improved
cardiovascular function and a more compliant patient
enjoying an improved quality of life.
ERYTHROPOIETIN BY CREATING INFORMATION
BROCHURE FOR PREDIALYSIS CKD PATIENTS
A. Karanfilovikj, L. Trajcheska, S. Sulejman, A. Canevska
Taneska, M. Milenkova Bogojevska, A. Spasovska Vasilova,
Z. Shterjova Markovska, J. Usprcov, V. Karanfilovski,
A. Stojanoska Severova, Z. Janevski, A. Memeti, S.
Filipovski, B. Bedzeti, I. Rambabova Bushljetikj
University Department for Nephrology, Faculty of
Medicine, University Ss Cyril and Methodius, Skopje,
N. Macedonia
PP
Introduction. Patients with chronic kidney disease
have a relatively deficient erythropoietin production,
and this is one of the most significant causes of anemia in this group. The disorder starts to develop when
the glomerular filtration rate drops below 60 mg/ml.
In it’s severe form, anemia decreases quality of life
and increases the risk of cardiovascular diseases and
mortality in this patients, so the implementation of
prevention and control measures is recommended.
Methods. In our institution, 54 predialysis CKD patients, with average age 69,44±15, have been regularly
followed and treated for anemia with subcutaneous
administration of ESA, mostly on weekly basis. Considering the numerous comorbidities of this group of
patients, in order to reduce frequent outpatient visits
and improving the quality of life, 30 (60%) patients
accepted to be educated on self-administration of EPO.
Results. We created an information brochure for patients, as an educational training material, with basic
information about the medication, how to administer,
side effects, contraindications and information about
safe storage and disposal.
Conclusion. The benefits of education through the
information brochure for self-application of EPO among
the group of predialysis CKD patients are improved
cardiovascular function and a more compliant patient
enjoying an improved quality of life.
Subjects
File(s)![Thumbnail Image]()
Loading...
Name
Bantao Suplement 1-24 _ FINAL 3.pdf
Size
6.7 MB
Format
Adobe PDF
Checksum
(MD5):ab7d2c1a37a7aa446b521c15a168690f